| |
| |
Rothman,
N., K. P. Cantor, A Blair, D Bush, JW Brock, K Helzlsouer, SH Zahm,
LL Needham, GR Pearson, RN Hoover, GW Comstock, PT Strickland. 1997.
A nested case-control study of non-Hodgkin lymphoma and serum organochlorine
residues. The
Lancet 350 (July 26): 240-244.
|
|
| |
The
graph at right shows the interaction between a contaminant (PCBs)
and a virus (EBV, or Epstein Barr Virus) from the results obtained
in a collaborative work involving the US National Cancer Institute
and the US Centers for Disease Control by Rothman et al.
(1977)
The
graph compares the relative risk of non-Hodgkin's lymphoma for three
conditions of exposure. On the left (above PCB), the two bars compare
groups of people with little exposure to Epstein Barr Virus but
either low (green) or high (blue) exposure to PCBs. Comparing these
two bars shows a slight but significant increase in risk of NHL. |

Rothman
et al. 1997 |
|
| |
The
pair of bars in the center (above EBV) compare people with relatively
low PCB exposure and either low (green) or high (blue) exposure
to Epstein Barr Virus. This shows no alteration in risk due to EBV
alone.
The
pair of bars on the right compare two groups of people: low EBV
and low PCB (green) vs. high EBV and high PCB (blue). This striking
result shows over a 20x increase in risk if exposure to both agents,
the contaminant and the virus, is simultaneous and relatively high.
This
result does not prove causation. It suggests, however, that an interaction
between the contaminant and the virus may be increasing the risk
to NHL dramatically. One hypothesis is that the contaminant, known
from animal studies to affect immune system function, is reducing
the ability of the human immune system to resist the impact of an
infectious agent. |
|
|